A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
Clinical trial NCT07710768 · RECRUITING
Trial details
- NCT number
- NCT07710768
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2027-04-07
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.